TYMS and neoplasm: With regards to the association of polymorphisms with the TNM staging system, only TYMS-28 3R/3R SNP was associated with decreased risk of tumor progression (OR = 0.55; 95% CI = 0.33–0.93; p = 0.023) (Table 3).